Site Archives
by page:
by month:
by category:
by post:
- Amylin, Lilly, and Alkermes Await FDA Decision on Byetta for Diabetes
- BioHorizon Health Technology Surveillance Update: February 8, 2010
- Oral Therapies for Multiple Sclerosis – Fingolimod (FTY 720) and Cladribine: How Close are Novartis and Merck KGaA to FDA Approval?
- Making Sense of Clinical Trials: A Guide for BioHorizon Clients
- MannKind’s AFREZZA vs. Pfizer’s Exubera: Will Inhaled Insulin Be Different This Time?
- ADVENTRX Pharmaceuticals, Inc. and the 505(b)(2) New Drug Application (NDA) for ANX-530
- Pneumococcal Disease In Children
- Wyeth vs. GSK: A Vaccine Showdown?
- OSI Pharmaceuticals and Genentech’s Tarceva Non-Small Cell Lung Cancer Therapy
- Nabi Biopharmaceuticals Altastaph for the Prevention and Treatment of Staph. Aureus Infections
- Abbott Labs ABT-874 for Treatment of Crohn’s Disease
- Nitromed’s BiDil Combination Therapy for Congestive Heart Failure
- Sanofi-Synthelabo’s Eloxatin for Postsurgical Treatment of Stage III Colon Cancer
- MedImmune’s CAIV-T Influenza Vaccine
- DePuy Spine’s Charite Artificial Disc for Replacement of Spinal Discs
- Eli Lilly and Sankyo’s CS-747 / Prasugrel for Acute Coronary Syndrome
- Wyeth’s Enbrel for treatment of Psoriasis
- Elan/Biogen Idec’s Antegren (Natalizumab) for Treatment of Multiple Sclerosis
- ID Biomedical’s FluInsure Influenza Vaccine
- Neurochem’s Alzhemed for treatment of Alzheimer’s
- Nymox Pharmaceutical NX-1207 for BPH
- Xenova Group’s TA-NIC for the Treatment of Nicotine Addiction
- Vytorin for the Treatment of Hyperlipidemia
- Matritech’s NMP179 for Detection of Cervical Cancer
- Lorus Therapeutics GTI-2040 for Colon Cancer
- Avanir Pharmaceuticals’ AVP 13358 for Asthma
- Amgen’s Enbrel for Psoriasis
- Iressa (Gefitinib) for Non Small Cell Lung Cancer
- Cordis Carotid System for Carotid Artery Disease
- CV Therapeutics’ Ranexa for Chronic Angina
- VaxGen’s rPA102 Recombinant Anthrax Vaccine
- DAC GLP-1 for Type II Diabetes
- Humira (adalimumab) for rheumatoid arthritis
- Torcetrapib for increasing HDL cholesterol
- Surveillance Summary Apr 3 – Apr 9, 2004
- Preos osteoporosis drug
- FM-VP4 for the treatment of hyperlipidemia
- Surveillance Summary Mar 27 – Apr 2, 2004
- OraQuick Rapid HIV Antibody Test
- Enoximone
- Surveillance Summary March 20 – 26, 2004
- Dexanabinol
- Zenapax (daclizumab)
- Surveillance Summary March 13 – 19, 2004
- Acomplia (rimonabant)
- Daxas (roflumilast)
- Surveillance Summary March 6 – 12, 2004
- Exubera
- Taxus Express
- Surveillance Summary Feb 25 – March 5, 2004
- Surveillance Summary Feb 14 – Feb 20, 2004
- CYPHER Sirolimus-eluting Stent
- Indiplon
- Visudyne
- Erbitux
- Surveillance Summary Feb 7 – Feb 13, 2004
- Surveillance Summary Jan 31 – Feb 6, 2004
- Namenda
- Avastin